Vaxcyte, Inc. 4

Vaxcyte Chief Technical Ops Officer Harpreet S. Dhaliwal surrendered 7,651 shares of common stock on 2026-09-08 at about $60.36 per share to cover RSU tax withholding, retaining 68,085 shares afterward.

On September 8, 2026, Harpreet S. Dhaliwal, Chief Technical Ops Officer of Vaxcyte, Inc., surrendered 7,651 shares of Vaxcyte common stock to the company at an implied price of approximately $60.36 per share, solely to cover tax withholding obligations arising from the vesting of previously granted restricted stock units (RSUs). This withholding transaction, reported with transaction code “F,” is a non-open-market, administrative event rather than a discretionary sale, and left Dhaliwal with direct ownership of 68,085 shares of Vaxcyte common stock following the transaction.

Filing Facts

CIK

1649094

Ticker

PCVX

Form

4

Source Type

fda

Accession

0001886794-26-000012

Alert Tier

5